Skip to content

Clinical trials

Completed Glucose Metabolism Disorders trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Status: Completed Country / region: Japan Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20141
20201
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Kyowa Kirin Co., Ltd.1
Takeda1
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1
Ultragenyx Pharmaceutical Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders8
Diabetes Mellitus7
Diabetes Mellitus, Type 26
Metabolic Diseases6
Endocrine System Diseases4
Acute Coronary Syndrome1
Coronary Artery Disease1
Diabetes Complications1
Diabetic Nephropathies1
Glycogen Storage Disease Type I1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.